A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia

This publication has 14 references indexed in Scilit:

• Section Review—Central & Peripheral Nervous Systems: Pre-Clinical Pharmacology of New Atypical Antipsychotics in Late Stage Development
  Expert Opinion on Investigational Drugs, 1995
• Effect of sertindole on raised mesolimbic dopaminergic activity in the rat
  Drug Development Research, 1994
• The efficacy and tolerability of sertindole in schizophrenic patients: A pilot, double-blind, placebo-controlled, dose-ringing study
  Schizophrenia Research, 1993
• Do central antiadrenergic actions contribute to the atypical properties of clozapine?
  1992
• Sertindole and several antipsychotic drugs differentially inhibit the discriminative stimulus effects of amphetamine, LSD and St 587 in rats
  Behavioural Pharmacology, 1992
• The acute effect of sertindole on brain 5-HT2, D2 and ?1 receptors (ex vivo radioreceptor binding studies)
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1992
• Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: Acute and repeated treatment
  Synapse, 1992
• Effects of antipsychotic drugs on serotonin receptors.
  1991
• Neurochemical and in vivo pharmacological profile of sertindole, a limbic‐selective neuroleptic compound
  Drug Development Research, 1991
• Antipsychotic drug effects on the electrical activity of dopaminergic neurons
  Trends in Neurosciences, 1984